Follow the Kilitch Drugs (India) Limited stock price and the full insider trade history of the company, a listed equity based in India. Shares are quoted on the IN market, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Kilitch Drugs (India) Limited has published 5 public disclosures. Market capitalisation: €6.5bn. The latest transaction was reported on 27 August 2024 (Sale). Among the most active insiders: Bhavin Mehta. All data is accessible without an account.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Kilitch Drugs (India) Limited 是一家从事药品制造的公司。它在孟买证券交易所运营。